Xarxa de bancs de tumors de Catalunya

  • Increase font size
  • Default font size
  • Decrease font size

IMAS - Hospital del Mar

Correu electrònic Imprimeix PDF

Investigador Responsable: Aquesta adreça electrònica s'està protegint contra robots de correu brossa, necessiteu que el JavaScript estigui habilitat per a mostrar-la

Descripció

Nom del Banc: MARBiobanc, Barcelona

Centre: Parc de Salut Mar, Barcelona

Institució: IMIM (Institut Hospital del Mar d'Investigacions Mèdiques) - IMAS Hospital del Mar, Barcelona

Breu Descripció: El Banc de Tumors del IMAS te mostres dels principals tumors i un bon número de mostres de tumors hematològics.

 

Personal

Nom Títol Categoria

Montserrat Torà Barnadas Dra. Directora científica
     
Aquesta adreça electrònica s'està protegint contra robots de correu brossa, necessiteu que el JavaScript estigui habilitat per a mostrar-la Dra.

Investigador Responsable

Erica Torres Tècnic

Tècnic de laboratori

Rebeca Rueda Tècnic

Tècnic de laboratori

Gemma Navarro Tècnic

Tècnic de laboratori

Activitats

  • Banc de tumors de pacients amb càncer de mama.
  • Banc de tumors de pacients amb neoplasies hematològiques.

 

Fons

 

 

Publicacions

  • Biomarkers characterization of circulating tumour cells in breast cancer patients.Nadal R, Fernandez A, Sanchez-Rovira P, Salido M, Rodríguez M, García-Puche JL, Macià M, Corominas JM, Delgado-Rodriguez M, Gonzalez L, Albanell J, Fernández M, Solé F, Lorente JA, Serrano MJ. Breast Cancer Res 2012; 14(3):R71.
  • Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer.Montagut C, Dalmases A, Bellosillo B, Crespo M, Pairet S, Iglesias M, Salido M, Gallen M, Marsters S, Tsai SP, Minoche A, Seshagiri S, Serrano S, Himmelbauer H, Bellmunt J, Rovira A, Settleman J, Bosch F, Albanell J. Nat Med 2012; 18(2):221-23. DOI: 10.1038/nm.2609.
  • Incidence of human papillomavirus infection in male sexual partners of women diagnosed with CIN II-III.Martín-Ezquerra G, Fuste P, Larrazabal F, Lloveras B, Fernandez-Casado A, Belosillo B, Mancebo G, Masferrer E, Segura S, Carreras R, Alameda F, Pujol RM. Eur J Dermatol 2012; 22(2):200-04. DOI: 10.1684/ejd.2011.1622.
  • TET2, ASXL1, IDH1, IDH2, and c-CBL genes in JAK2- and MPL-negative myeloproliferative neoplasms. Martínez-Avilés L, Besses C, Álvarez-Larrán A, Torres E, Serrano S, Bellosillo B. Ann Hematol 2012; 91(4):533-41. DOI: 10.1007/s00277-011-1330-0.
  • Primary bone marrow lymphoma: an uncommon extranodal presentation of aggressive non-hodgkin lymphomas. Martinez A, Ponzoni M, Agostinelli C, Hebeda KM, Matutes E, Peccatori J, Campidelli C, Espinet B, Perea G, Acevedo A, Mehrjardi AZ, Martinez-Bernal M, Gelemur M, Zucca E, Pileri S, Campo E, López-Guillermo A, Rozman M; International Extranodal Lymphoma Study Group. Am J Surg Pathol 2012; 36(2):296-304. DOI: 10.1097/PAS.0b013e31823ea106.
  • Update on developments in the diagnosis and prognostic evaluation of patients with myelodysplastic syndromes (MDS): consensus statements and report from an expert workshop.Platzbecker U, Santini V, Mufti GJ, Haferlach C, Maciejewski JP, Park S, Solé F, van de Loosdrecht AA, Haase D.Leuk Res 2012; 36(3):264-70. DOI: 10.1016/j.leukres.2011.11.005.
  • Influence of JAK2 46/1 haplotype in the natural evolution of JAK2V617F allele burden in patients with myeloproliferative neoplasms. Alvarez-Larrán A, Angona A, Martínez-Avilés L, Bellosillo B, Besses C. Leuk Res 2012; 36(3):324-26. DOI: 10.1016/j.leukres.2011.09.029.
  • Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia vera.Alvarez-Larrán A, Pereira A, Cervantes F, Arellano-Rodrigo E, Hernández-Boluda JC, Ferrer-Marín F, Angona A, Gómez M, Muiña B, Guillén H, Teruel A, Bellosillo B, Burgaleta C, Vicente V, Besses C. Blood 2012; 119(6):1363-69. DOI: 10.1182/blood-2011-10-387787.
  • Are ER+PR+ and ER+PR- breast tumors genetically different? A CGH array study. Carracedo A, Salido M, Corominas JM, Rojo F, Ferreira BI, Suela J, Tusquets I, Corzo C, Segura M, Espinet B, Cigudosa JC, Arumi M, Albanell J, Serrano S, Solé F. Cancer Genet 2012; 205(4):138-46. DOI: 10.1016/j.cancergen.2012.01.001.
  • In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior. Carvajal-Cuenca A, Sua LF, Silva NM, Pittaluga S, Royo C, Song JY, Sargent RL, Espinet B, Climent F, Jacobs SA, Delabie J, Naresh KN, Bagg A, Brousset P, Warnke RA, Serrano S, Harris NL, Swerdlow SH, Jaffe ES, Campo E. Haematologica. 2012 Feb;97(2):270-8. doi: 10.3324/haematol.2011.052621.
  • Seeking genetic susceptibility variants for colorectal cancer: the EPICOLON consortium experience. Castellví-Bel S, Ruiz-Ponte C, Fernández-Rozadilla C, Abulí A, Muñoz J, Bessa X, Brea-Fernández A, Ferro M, Giráldez MD, Xicola RM, Llor X, Jover R, Piqué JM, Andreu M, Castells A, Carracedo A; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Morillas JD, Muñoz R, Manzano M, Colina F, Díaz J, Ibarrola C, López G, Ibáñez A, Castells A, Piñol V, Castellví-Bel S, Balaguer F, Gonzalo V, Ocaña T, Giráldez MD, Pellise M, Serradesanferm A, Moreira L, Cuatrecasas M, Pique JM, Lanas Á, Alcedo J, Ortego J, Cubiella J, Díez MS, Salgado M, Sánchez E, Vega M, Andreu M, Abulı A, Bessa X, Iglesias M, Seoane A, Bory F, Navarro G, Bellosillo B, Dedeu JM, ÁLvarez C, Puigvehı M, Bujanda L, Cosme Á, Gil I, Larzabal M, Placer C, del Mar Ramírez M, Hijona E, Enríquez-Navascués JM, Elosegui JL, Paya A, Jover R, Alenda C, Sempere L, Acame N, Rojas E, Pérez-Carbonell L, Rigau J, Serrano Á, Giménez A, Salo J, Batiste-Alentorn E, Autonell J, Barniol R, García AM, Carballo F, Bienvenido A, Sanz E, González F, Sánchez J, Ono A, Latorre M, Medina E, Cuquerella J, Canelles P, Martorell M, García JÁ, Quiles F, Orti E, Clofent J, Seoane J, Tardío A, Sanchez E, de Castro ML, Tardío A, Clofent J, Hernández V, Llor X, Xicola RM, Piñol M, Rosinach M, Roca A, Pons E, Hernández JM, A M, Fernández-Bañares F, Viver JM, Salas A, Espinós J, Forne M, Esteve M, Reñé JM, Piñol C, Buenestado J, Viñas J, Quintero E, Nicolás D, Parra A, Martín A, Argüello L, Pons V, Pertejo V, Sala T, Gonzalez D, Roman E, Ramon T, Poca M, Mar M, Martin M, Pétriz L, Martinez D, de Medicina Xenomica PG, Carracedo Á, Ruiz-Ponte C, Fernández- Rozadilla C, Castro MM, Riestra S, Rodrigo L, Fernández J, Cabriada JL, Carreño L, Oquiñena S, Bolado F, Peña E, Manuel Blas J, Ceña G, Sebastián JJ, Naranjo A. Mutagenesis 2012; 27(2):153-59. DOI: 10.1093/mutage/ger047.
  • Will a peripheral blood (PB) sample yield the same diagnostic and prognostic cytogenetic data as the concomitant bone marrow (BM) in myelodysplasia?. Cherry AM, Slovak ML, Campbell LJ, Chun K, Eclache V, Haase D, Haferlach C, Hildebrandt B, Iqbal AM, Jhanwar SC, Ohyashiki K, Sole F, Vandenberghe P, VanDyke DL, Zhang Y, Dewald GW. Leuk Res 2012; 36(7):832-40. DOI: 10.1016/j.leukres.2012.03.013.
  • Better prognosis for patients with del(7q) than for patients with monosomy 7 in myelodysplastic syndrome. Cordoba I, González-Porras JR, Nomdedeu B, Luño E, de Paz R, Such E, Tormo M, Vallespi T, Collado R, Xicoy B, Andreu R, Muñoz JA, Solé F, Cervera J, del Cañizo C; Spanish Myelodysplastic Syndrome Registry. Cancer 2012; 118(1):127-33. DOI: 10.1002/cncr.26279.
  • Expression of MALT1 oncogene in hematopoietic stem/progenitor cells recapitulates the pathogenesis of human lymphoma in mice. Vicente-Dueñas C, Fontán L, Gonzalez-Herrero I, Romero-Camarero I, Segura V, Aznar MA, Alonso-Escudero E, Campos-Sanchez E, Ruiz-Roca L, Barajas-Diego M, Sagardoy A, Martinez-Ferrandis JI, Abollo-Jimenez F, Bertolo C, Peñuelas I, Garcia-Criado FJ, García-Cenador MB, Tousseyn T, Agirre X, Prosper F, Garcia-Bragado F, McPhail ED, Lossos IS, Du MQ, Flores T, Hernandez-Rivas JM, Gonzalez M, Salar A, Bellosillo B, Conde E, Siebert R, Sagaert X, Cobaleda C, Sanchez-Garcia I, Martinez-Climent JA. Proc Natl Acad Sci U S A 2012; 109(26):10534-39. DOI: 10.1073/pnas.1204127109.
  • Cutis laxa-like mycosis fungoides. López Aventín D, Gallardo F, Gil I, Martín-Ezquerra G, García M, Bellosillo B, Juanpere N, Pujol RM. J Dermatol 2012; 39(6):548-51. DOI: 10.1111/j.1346-8138.2012.01523.x.
  • Keratinocytic epidermal nevi are associated with mosaic RAS mutations. Hafner C, Toll A, Gantner S, Mauerer A, Lurkin I, Acquadro F, Fernández-Casado A, Zwarthoff EC, Dietmaier W, Baselga E, Parera E, Vicente A, Casanova A, Cigudosa J, Mentzel T, Pujol RM, Landthaler M, Real FX. J Med Genet 2012; 49(4):249-53. DOI: 10.1136/jmedgenet-2011-100637.
  • Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome. Groesser L, Herschberger E, Ruetten A, Ruivenkamp C, Lopriore E, Zutt M, Langmann T, Singer S, Klingseisen L, Schneider-Brachert W, Toll A, Real FX, Landthaler M, Hafner C. Nat Genet. 2012 Jun 10;44(7):783-7. doi: 10.1038/ng.2316.
  • Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer. Rojo F, García-Parra J, Zazo S, Tusquets I, Ferrer-Lozano J, Menendez S, Eroles P, Chamizo C, Servitja S, Ramírez-Merino N, Lobo F, Bellosillo B, Corominas JM, Yelamos J, Serrano S, Lluch A, Rovira A, Albanell J. Ann Oncol 2012; 23(5):1156-64. DOI: 10.1093/annonc/mdr361.
  • ALK status in a primary lung tumour and metachronous metastases. Salido M, Pijuan L, Galván AB, Gimeno J, Cañadas I, Rodriguez-Rivera M, Rojo F, Albanell J, Solé F, Arriola E. Histopathology 2012; 60(5):843-5. DOI: 10.1111/j.1365-2559.2011.04100.x.
  • New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge. Schanz J, Tüchler H, Solé F, Mallo M, Luño E, Cervera J, Granada I, Hildebrandt B, Slovak ML, Ohyashiki K, Steidl C, Fonatsch C, Pfeilstöcker M, Nösslinger T, Valent P, Giagounidis A, Aul C, Lübbert M, Stauder R, Krieger O, Garcia-Manero G, Faderl S, Pierce S, Le Beau MM, Bennett JM, Greenberg P, Germing U, Haase D. J Clin Oncol 2012; 30(8):820-29. Doi: 10.1200/JCO.2011.35.6394.
  • Functional polymorphisms in SOCS1 and PTPN22 genes correlate with the response to imatinib treatment in newly diagnosed chronic-phase chronic myeloid leukemia. Guillem V, Amat P, Cervantes F, Alvarez-Larrán A, Cervera J, Maffioli M, Bellosillo B, Collado M, Marugán I, Martínez-Ruiz F, Hernández-Boluda JC. Leuk Res 2012; 36(2):174-81. DOI: 10.1016/j.leukres.2011.06.011.
  • A polymorphism in the XPD gene predisposes to leukemic transformation and new nonmyeloid malignancies in essential thrombocythemia and polycythemia vera. Hernández-Boluda JC, Pereira A, Cervantes F, Alvarez-Larrán A, Collado M, Such E, Arilla MJ, Boqué C, Xicoy B, Maffioli M, Bellosillo B, Marugán I, Amat P, Besses C, Guillem V. Blood 2012; 119(22):5221-28. DOI: 10.1182/blood-2012-02-411215.
  • B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen.Puga I, Cols M, Barra CM, He B, Cassis L, Gentile M, Comerma L, Chorny A, Shan M, Xu W, Magri G, Knowles DM, Tam W, Chiu A, Bussel JB, Serrano S, Lorente JA, Bellosillo B, Lloreta J, Juanpere N, Alameda F, Baró T, de Heredia CD, Torán N, Català A, Torrebadell M, Fortuny C, Cusí V, Carreras C, Diaz GA, Blander JM, Farber CM, Silvestri G, Cunningham-Rundles C, Calvillo M, Dufour C, Notarangelo LD, Lougaris V, Plebani A, Casanova JL, Ganal SC, Diefenbach A, Aróstegui JI, Juan M, Yagüe J, Mahlaoui N, Donadieu J, Chen K, Cerutti A. Nat Immunol 2011; 13(2):170-80. DOI: 10.1038/ni.2194.
  • Key contribution of CPEB4-mediated translational control to cancer progression. Ortiz-Zapater E, Pineda D, Martínez-Bosch N, Fernández-Miranda G, Iglesias M, Alameda F, Moreno M, Eliscovich C, Eyras E, Real FX, Méndez R, Navarro P. Nat Med 2011; 18(1):83-90. DOI: 10.1038/nm.2540.
  • Polysomy of chromosome 17 in breast cancer tumors showing an over-expression of ERBB2: a study of 175 cases using Fluorescence in situ Hybridization and Immunohistochemistry. Salido M, Tusquets I, Corominas JM, Suarez M, Espinet B, Corzo C, Bellet M, Fabregat X, Serrano S, Solé F. Breat Cancer Research 2005; 7(2):267-73.
  • Clonality analysis by HUMARA assay in spanish females with essential thrombocythemia and polycythemia vera. Zamora L, Espinet B, Florensa L, Besses C, Bellosillo B, Solé F. Haematologica 2005; 90(2):259-61.
  • Characterization of HER1 (c-erbB1) Status in Locally Advanced Breast Cancer Using Fluorescence in situ Hybridization and Immunohistochemistry. Corzo C, Tusquets I, Salido M, Corominas JM, Bellet M, Suarez M, Baro T, Fabregat X, Serrano S, Solé F. Tumour Biol 2005; 26(1):25-30.
  • Clonal cytogenetic abnormalities in patients with chronic myeloid leukemia in complete cytogenetic response to imatinib mesylate. Espinet B, Olivera AC, Boque C, Domingo A, Alonso E, Solé F. Haematologica 2005; 90(4):556-68.
  • Correlation between histologic findings and cytogenetic abnormalities in bladder carcinoma: a FISH study. Placer J, Espinet B, Salido M, Solé F, Gelabet-Mas A. Urology 2005, 65(5):913-18.
  • Cytogenetic and fish studies in 60 patients with multiple myeloma and plasma cell leukemia. Lloveras E, Granada I, Zamora L, Espinet B, Florensa L, Besses C, Xandri M, Pérez-Vila E, Millà F, Woessner S, Solé F. Cancer Genet Cytogenet 2004, 148(1):71-6.
  • Two cases of tetrasomy 9p syndrome with tissue limited mosaicism". American Journal of Medical Genetics . Lloveras E, Pérez C, Solé F, Zamora L, Lladonosa A, Espinet B, Silvestre E, Serra J, Vendrell T, Fernández B, Salido M, Plaja A. Am J Med Genet 2.004; 124A (4):402-06.
  • Type I MOZ/CBP (MYST3/CREBBP) is the Most Common Chimeric Transcript In Acute Myeloid Leukemia With the t(8;16)(p11;p13) Translocation. Rozman M, Camós M, Colomer D, Villamor N, Esteve J, Costa D, Carrió A, Aymerich A, Aguilar JLL, Domingo A, Solé F, Gomis F, Florensa L, Monserrat E, Campo E. Genes Chromosomes and Cancer 2004; 40(2):140-45.
  • Genetic characterization of Sezary syndrome: application of conventional cytogenetics and cross species color banding. Espinet B, Salido M, Pujol R, Florensa L, Domingo A, Servitje O, Estrach T, Vallespi T, Teixido M, Zamora L, Woessner S, Serrano S, Solé F. Haematologica 2004; 89(2):165-73.
  • Comparative Analysis of TCR-g Gene Rearrangements by Genescan and Polyacrylamide Gel-electrophoresis in Cutaneous T-cell Lymphoma. Costa C, Gallardo F, Pujol RM, Espinet B, Bellosillo B, Estrach T, Servitje O, Barranco C, Serrano S, Solé F. Acta Dermatol Venerol 2004; 84:6-11.
  • Endogenous erythroid and megakaryocytic circulating progenitors, HUMARA clonality assay, and PRV-1 expression are useful tools for diagnosis of polycythemia vera and essential thrombocythemia. Florensa L, Besses C, Zamora L, Bellosillo B, Espinet B, Serrano S, Woessner S, Solé F. Blood 2004; 103(6):2427-28.
  • Heterogeneity of structural abnormalities in the 7q31.3 approximately q34 region inmyeloid malignancies. González MB, Gutierrez NC, García JL, Schoenmakers EF, Solé F, Calazans MJ, San Miguel JF, Hernández JM. Cancer Genet Cytogenet 2004; 150(2):136-43.
  • Is fluorescence in situ hybridization a useful method in diagnosis of polycythemia vera patients?. Zamora L, Espinet B, Florensa L, Besses C, Woessner S, Serrano S, Solé F. Cancer Genetics Cytogenetics 2004; 151(2):139-45.
  • Genetic diagnosis by comparative genomic hybridization in adult de novo acute myelocytic leukemia. Casas S, Aventin A, Fuentes F, Vallespi T, Granada I, Carrió A, Marténz-Climent J, Solé F, Teixido M, Bernues M, Duarte J, Hernández J, Brunet S, Coll M, Sierra J. Cancer Genetics Cytogenetics 2004; 153(1):16-25.
  • Intratumoral heterogeneity of HER2/neu and topoisomerase II alpha in breast cancer: a case with clonal monosomy 17. Corzo C, Tusquets I, Suarez M, Fabregat X, Salido M, Corominas JM, Serrano S, Solé F. Cancer Genet Cytogenet. 2004; 154(1):89-90.
  • Absence of MALT1 translocations in primary cutaneous marginal zone B-cell lymphoma. Espinet B, Gallardo F, Pujol RM, Estrach T, Servitje O, Solé F. Haematologica. 2004; 89(9):ELT14.
  • Activation of mitochondrial pathway in mantle cell lymphoma: high sensitivity to mitoxantorne in cases with functional DNA-damage response genes. Ferrer A, Marce S, Bellosillo B, Villamor N, Bosch F, López-Guillermo A, Espinet B, Solé F, Monserrat E, Campo E, Colomer D. Oncogene 2004:1-9.
  • Lymphomatoid papulosis associated wuth mycosis fungoides. Clinicopatohological and molecular study of 12 cases. Gallardo F, Costa C, Bellosillo B, Solé F, Estrach T, Servitje O, García-Muret MP, Barranco C, Serrano S, Pujol RM. Acta Dermatol 2004; 84 (6):463-68.
  • A new translocation t(11;13) (q13;q14) in a mature B-cell neoplasm. Haematologica 2002; 87(7):777-78.
  • Incidence of trisomy 8 and 9, deletion of D13S319 and D20S108 loci and BCR/ABL translocation in non-treated essential thrombocythemia patients: an analysis of bone marrow cells using interphase fluorescence in situ hybridization. Zamora L, Espinet B, Florensa L, Besses C, Salido M, Solé F. Haematologica 2003; 88(1):110-11.
  • HLA-G positive trophoblastic cells in trancervical samples and their isolation by laser microdissection and QF-PCR. Bulmer JN, Cioni R, Bussani C, Cirigliano V, Solé F, Costa C, García P, Adinolfi A. Prenatal Diagnosis 2003; 23(1):34-9.
  • Chimeric BCR/ABL gene detected by fluorescence in situ hybridization in three new cases of Philadelphia chromosome-negative chronic myeloid leukemia". Costa D, Espinet B, Queralt R, Carrió A, Solé F, Colomer D, Cervantes F, Angel-Hernández JA, Besses C, Campo E. Cancer Genet Cytogenet 2003; 141:114-19.
  • MLL intrachromosomal amplification in a pre-B acute lymphoblastic leukemia. Espinet B, Florensa L, Salido M, Solé F. Haematologica 2003; 88(01):EIM03.
  • Molecular heterogeneity in MCL, defined by the use of specific VH genes and the frequency of somatic mutations. Camacho F, Algara P, Rodríguez A, Ruíz-Ballesteros E, Mollejo M, Martínez N, Martínez-Climent JA, González M, Mateo M, Caleo A, Sánchez-Beato M, Menárguez J, García-Conde J, Solé F, Campo E, Piris MA. Blood 2003; 101(10):4042-46.
  • Additional isochromosome 1q in a primitive neuroectodermal tumour type merkel cell carcinoma as a primary cytogenetic change. Corzo C, Espinet B, Lloreta J, Salido M, Iglesias M, Serrano S, Solé F. Cancer Genet Cytogenet 2003; 142(2):165-67.
  • De novo erythroleukemia chromosome features include multiple rearrangements, with special involvement of chromosomes 11 and 19. Cigudisad JC, Odero MD, Calazanz MJ, Solé F, Salido M, Arranz E, Martínez-Ramírez A, Urioste M, Alvarez S, CerveraA JV, MacGragan D, Sanz MA, Nimer SD, Benítez J. Genes Chromosomes Cancer 2003; 36(4):406-12.
  • RxFISH karyotype and MYC amplification in the HT-29 colon adenocarcinoma cell line. Corzo C, Petzold M, Mayol X, Espinet B, Salido M, Serrano S, Real FX, Solé F. Genes Chromosomes Cancer 2003; 36(4):319-20.
  • Genomic abnormalities acquired in the blastic transformation of splenic marginal zone B-cell lymphoma. Martínez-Climent JA, Sánchez-Izquierdo D, Sarsotti E, Blesa D, Benet I, Climent J, Vizcarra E, Marugan I, Terol MJ, Solé F, Cigudisad JC, Siebert R, Dyer MJ, García-Conde J. Leukemia and Lymphoma 2003, 44(3):459-64.
  • Genomic rearrangements involving ribosomal DNA and centromeric heterochromatin in vulvar epidermoid carcinoma cell line A-431. Pedrazzini E, Mamaev N, Yakovleva T, Sukfikh T, Salido M, Solé F, Prat E, Camps J, Miró R, Slavutsky I. Cancer Genet Cytogenet 2003; 143:50-8.
  • Cytogenetic findings in familial B-chronic lymphocytic leukemia: a purpose of a two-case family.Espinet B, Salido M, Hernández JA, Zamora L, Bosch MA, Serrano S, Solé F. Cancer Genet Cytogenet 2003; 143(2):172-73.
  • Absence of ATM deletions in 16 cases of splenic marginal zone B-cell lymphoma. Salido M, Astier L, Puigdecanet E, Espinet B, Florensa L, Solé F. Haematologica 2003; 88(11):ELT33.
  • Pentasomy 21 with two isochromosomes 21 in a case of acute myeloid leukemia without maturation. Salido M, Sole F, Espinet B, Zamora L, Rodon N, Woessner S, Florensa L. Cancer Genet Cytogenet 2002; 132(1):71-3.
  • Translocation t(5;17) (q13;q21) in a case with precursor T-lymphoblastic lymphoma/leukemia. Zamora L, Espinet B, Solé F, Salido M, Rodon N, Woessner S, Florensa L. Cancer Genet Cytogenet 2002; 132(1):81-2.
  • Cytogenetic and in situ hybridization findings in a series of MGUS. Lloveras E, Solé F, Espinet B, Florensa L, Woessner S. Cancer Genet Cytogenet 2002; 132(1):25-9.
  • Collection of Philadelphia-negative stem cells using recombinant human granulocyte colony-stimulating factor in chronic myeloid leukemia patients treated with alpha-interferon".Hernández-Boluda JC, Carreras E, Cervantes F, Marín P, Orellano-Rodrigo E, Rovira M, Solé F, Lloveras E, Espinet B, Ocejo A, Monserrat E. Haematologica 2002; 87(1):17-22.
  • A new case of acute nonlymphocytic leukemia (FAB M1 subtype) with double minutes and C-MYC amplification. Rodon N, Solé F., Espinet B, Salido M, Zamora L, Cigudosa JC, Woessner S, Florensa L. Cancer Genet Cytogenet 2001; 132:161-64.
  • Monosomy 15 in chronic myelomonocytic leukemia: description of a case and review of the literature. Zamora L, Espinet B, Salido M, Florensa L, Woessner S, Pedro C, Serrano S, Solé F. Cancer Genet Cytogenet 2002; 134(2):165-67.
  • Cultures of myeloid progenitor cells in pediatric essential thrombocythemia. Florensa L, Zamora L, Besses C, Ortega JJ, Bastida P, Toll T, Mayayo P, Espinet B, Solé F, Serrano S, Woessner S. Leukemia 2002; 16 (9):1876-77.
  • Analysis of IgVh somatic mutations in SMZL defines a group of unmutated cases with frequent 7q deletion and adverse clinical outcome. Algara P, Mateo P, Sanchez-Beato M. Molejo M, Navas IC, Romero L, Solé F, Salido M, Forensa L, Martinez P, Campo E, Piris MA. Blood 2002; 99 (4):1299-304.
  • Acute erythorid neoplastic proliferations. A biological study based on 62 patients. Domingo-Claros A, Larriba I, Rozman M, Irriguible D, Vallepí T, Aventin A, Ayats R, MIillà F, Solé F, Florensa L, Gallard M, Tuset E, Lopez C, Woessner S. Haematologica 2002; 87(2):148-53.
  • Genetic imbalances in progressed B-cell chronic lymphocytic leukemia and Transformed large cell lymphoma (Richter's syndrome). Beà S, López-Guillermo A, Ribas M, Puig X, Pinyol M, Carrió A, Zamora L, Solé F, Bosch F, Stilgenbauer S, Colomer D, Miró R, Monserrat E, Campo E. American Journa Pathology 2002; 161(3):957-68.
  • Report of 46,XX/46,XY/47,XXY/48,XXYY mosaicism in an adult phenotypic male. Zamora L, Espinet B, Solé F, LigorriaC, Salido M, Florensa L. American Journal of Medical Genetics 2002; 111:215-17.
  • Cardiomyocytes from Mesenchymal Cells in Sex-Mismatch Cardiac Allografts. Bayes-Genis A, Salido M, Solé F, Ristol F, Puig M, Bossa V, Campreciòs M, Corominas JM, Mariñoso ML, Baró T, Vela MC, Serrano S, Padró JM, Bayes de Luna A, Schwartz RS, Cinca J. Cardiovascular Research 2002; 56(3):357-58.
  • Genetic characterization of the paraimmunoblastic variant of small lymphocytic lymphoma/chronic lymphocytic leukemia: a case report and review of the literature. Espinet B, Larriba I, Salido M, Florensa L, Woessner S, Sans-Sabrafen J, Barranco C, Serrano S, Solé F. Human Pathology 2002; 33(11):1145-48.
  • Clinical utility of a multiprobe FISH assay in voided urine specimens for the detection of bladder cancer and its recurrences, compared with urinary cytology.Placer J, Espinet B, Salido M, Solé F, Gelabert-Mas. European Urology 2002; 42:547-52.

Equip i tècniques

  • 6 congeladors -80ºC
  • 3 congeladors -20ºC
  • 1 combi A PLUS
  • 1 nevera Crypton
  • 1 nano drop Espectrophotometer
  • 1 comptador de cèl·lules Coulter
  • 1 extractor de àcids nucleics QIACUBE
  • 1 extractor de àcids nucleics RBC MagCore Super
  • 1 extractor de àcids nucleics Genovison M48
  • 1 cuba de nitrògen
  • Obtenció de talls de blocs de teixit inclòs en parafina
  • Obtenció de talls de blocs de teixit congelat en OCT
  • Obtenció de cèl·lules mononuclears (ficoll)
  • Separació de leucòcits mitjançant gradients de densitat (dextrà)
  • Criopreservació de cèl·lules
  • Extracció d'àcids nucleics
  • Extracció d'ADN circulant
  • Extracció d'ADN de parafina
  • Quantificació d'àcids nucleics
  • Mesura de la qualitat de l'ADN (PCR)

Altres